$23.26
0.56% yesterday
NYSE, Sep 27, 10:19 pm CET
ISIN
US49177J1025
Symbol
KVUE
Index
Sector
Industry

Kenvue Stock price

$23.26
+1.34 6.11% 1M
+1.81 8.44% 6M
+1.73 8.04% YTD
+3.04 15.03% 1Y
-3.64 13.53% 3Y
-3.64 13.53% 5Y
-3.64 13.53% 10Y
NYSE, Closing price Fri, Sep 27 2024
+0.13 0.56%
ISIN
US49177J1025
Symbol
KVUE
Index
Sector
Industry

Key metrics

Market capitalization $44.30b
Enterprise Value $51.89b
P/E (TTM) P/E ratio 39.61
EV/FCF (TTM) EV/FCF 29.30
EV/Sales (TTM) EV/Sales 3.35
P/S ratio (TTM) P/S ratio 2.86
P/B ratio (TTM) P/B ratio 4.35
Dividend yield 1.73%
Last dividend (FY23) $0.40
Revenue growth (TTM) Revenue growth 0.42%
Revenue (TTM) Revenue $15.47b
EBIT (operating result TTM) EBIT $2.90b
Free Cash Flow (TTM) Free Cash Flow $1.77b
Cash position $1.01b
EPS (TTM) EPS $0.58
P/E forward 32.73
P/S forward 2.83
EV/Sales forward 3.31
Short interest 2.15%
Show more

Is Kenvue a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.

Kenvue Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a Kenvue forecast:

8x Buy
42%
10x Hold
53%
1x Sell
5%

Analyst Opinions

19 Analysts have issued a Kenvue forecast:

Buy
42%
Hold
53%
Sell
5%

Financial data from Kenvue

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
15,474 15,474
-
100%
- Direct Costs 6,587 6,587
-
43%
8,887 8,887
-
57%
- Selling and Administrative Expenses 4,950 4,950
-
32%
- Research and Development Expense 416 416
-
3%
3,521 3,521
-
23%
- Depreciation and Amortization 617 617
-
4%
EBIT (Operating Income) EBIT 2,904 2,904
-
19%
Net Profit 1,119 1,119
-
7%

In millions USD.

Don't miss a Thing! We will send you all news about Kenvue directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Kenvue Stock News

Neutral
Business Wire
5 days ago
SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) is releasing its first Task Force on Climate-related Financial Disclosures (TCFD) report.
Positive
Seeking Alpha
15 days ago
"What is a Dividend King? A stock with 50 or more consecutive years of dividend increases.” - suredividend.com. The 53 Dividend Kings, screened as of Sept. 10, represented eight of 11 Morningstar Sectors. Broker-targeted top 10 net gains ranged around 11.59%-35.94%, topped by Emerson and Stephan. By yield, Altria tops all. Top 10 September dogs: HRL, KVUE, FRT, FTS, UBSI, BKH, NWN, CDUAF, UVV, ...
Positive
Seeking Alpha
17 days ago
The S&P 500 Dividend Aristocrats list was rebalanced in January 2024, with notable changes including the removal of Walgreens and 3M, and the addition of Fastenal and Kenvue.
More Kenvue News

Company Profile

Kenvue, Inc. engages in the provision of healthcare products services. It operates through the following business segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care and hair, sun and others. The Essential Health segment includes oral care, baby care, women’s health and wound care. The company was founded on February 23, 2022 and is headquartered in Skillman, NJ.

Head office United States
CEO Thibaut Mongon
Employees 22,000
Website www.kenvue.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today